Compass Pathways PLC (CMPS) Stock Price, Quote, News & History

CMPSNASDAQ
$12.23
0.827.19%
Last update: Jun 12, 12:43 PM

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-159.52M
Investing Cash Flow (TTM)
-
Financing Cash Flow (TTM)
362.81M
Free Cash Flow (TTM)
-159.52M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
203.29M

Analyst Trends and Forecast

1
Jan
3
Feb
3
Mar
3
Apr
5
May
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.9
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$1.13B
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
4.71
Earnings Yield % (TTM)
-27.52%
Earnings Yield % (FWD)
-8.24%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$2.42

Company Debt

Total Debt
$50.48M
LT Debt
$50.48M
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$466.01M
Debt to Equity
0.16
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$11.48
Close
-
Volume / Avg.
1.63M / 4.04M
Day Range
$11.45 - $12.37
52 Wk Range
2.25 - 14.76
Market Cap
$1.65B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
57
Short Interest
5.5%
Days to Cover
1.71

About

Sector
Health Care
Industry
Biotechnology
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Compass Pathways (CMPS) stock?

A

You can purchase shares of Compass Pathways (NASDAQ:CMPS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Compass Pathways (CMPS) competitors?

A

There are no as such competitors for Compass Pathways.

Q

What is the forecast, or price target, for Compass Pathways (CMPS) stock?

A

Compass Pathways has a consensus price target of $22.25.

Q

What is the current price for Compass Pathways (CMPS)?

A

The stock price for Compass Pathways (NASDAQ: CMPS) is $12.23 last updated June 12, 2026 at 12:43 PM EDT.

Q

Does Compass Pathways (CMPS) pay a dividend?

A

There are no upcoming dividends for Compass Pathways.

Q

When is Compass Pathways (NASDAQ:CMPS) reporting earnings?

A

Compass Pathways does not have any upcoming earnings scheduled.

Q

Is Compass Pathways (CMPS) going to split?

A

There is no upcoming split for Compass Pathways.

Q

What sector and industry does Compass Pathways (CMPS) operate in?

A

Compass Pathways is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.